Please login to the form below
DH
This page shows the latest DH news and features for those working in and with pharma, biotech and healthcare.
UK appoints pharma veteran to 'streamline' NHS costs
The UK has recruited pharma veteran Steve Oldfield to fill the newly-created role of chief commercial officer at the Department of Health (DH). ... His extensive experience in senior pharmaceutical roles as UK managing director for Sanofi and Teva will
Latest news
-
Sarah Matthew crowned Healthcare Communiquétor 2017
So much of her senior consulting is confidential that few people know of her amazing achievements with leading industry bodies such as the ABPI and the DH, and with industry leaders
-
Pharma could make more of its real world evidence
The report, published in February 2016, says it is 'unacceptable' that, six years after the CDF was set up, the DH and NHS England still do not have data to evaluate ... When the CDF was introduced in 2010, the DH 'encouraged' trusts to collect data to
-
UK pharma rebate payment doubles in one year
The ABPI, which negotiated the deal with DH in 2013, is keen to see this as 'underwriting' the NHS medicines bill.
-
Is a UK market access shake-up on the cards?
But the secrecy around these deals irks health economists and doctor groups, as without knowing how much has been knocked off the price that no one outside NICE, the DH and ... I do, however, think there are issues about these commercially confidential
-
Pharma must engage on the affordability question, says ABPI
The rebates should be helping this, but the ABPI and many other senior executives in the industry told PMLiVE that this money is going back to the DH and NHS England,
More from news
Approximately 2 fully matching, plus 167 partially matching documents found.
Latest Intelligence
-
Public affairs
Healthcare terms - Public affairs.
-
Healthcare systems
Healthcare terms - Healthcare systems.
-
Pharma perspectives: communications creativity (part 2)
Is pharma marketing less creative than its consumer sector? DH: That old chestnut eh! ... DH: The simple answer is yes! How we do it is another matter.
-
NICE and ‘ultra orphans’
Provisional evaluation topics chosen by the Department of Health (DH). Consultees and commentators identified. ... Scope prepared by NICE and DH. Evaluation topics officially referred to NICE by DH.
-
Drug pricing in Ireland
The agreement between the Department of Health (DH), the Health Service Executive (HSE) and the Irish Pharmaceutical Healthcare Association (IPHA) will lead to significant reductions in the prices of both ... The three-year pricing agreement. The latest
More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest appointments
-
New health ministers and re-appointments after reshuffle
Two noticeable absences are Lord Freddy Howe, who has moved out of the DH and over to the Ministry of Defence and David Willetts, formerly the universities and science minister, who
-
UK names guardian for national health data
The UK's Department of Health (DH) has appointed Dame Fiona Caldicott as the nation's guardian for health and care data. ... According to the DH, Dame Fiona will be the “ patients' champion on security of personal medical information” to guarantee
-
NHS names ‘procurement champion’
This broad experience is likely to have been one of the reasons the DH was keen to appoint Lord Carter to his new position.
-
New chair of the British Pharmacopoeia Commission
The UK's Department of Health (DH) has named Prof Kevin Taylor as the new chair of the British Pharmacopoeia Commission (BPC).
-
DH names new chief executive of the MHRA
DH names new chief executive of the MHRA. Ian Hudson to lead UK medicines regulator.
More from appointments
Approximately 2 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals. Creatively driven, media savvy, technology fueled, Digitas Health is a leading brand
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Senior Systematic Review Analyst - Oxford
-
Negotiable
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
- Events Manager – Med Comms – Surrey
-
Salary TBC
-
Senior Account Manager
-
Negotiable
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
-
Consumer Health Account Director
-
Circa £60, 000 Gym and More
-
Associate Medical Director
-
Highly Competitive
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Medical/ Scientific Director
-
Salary TBC
-
New Business Director - PR
-
Competitive Salary and benefits
Subscribe to our email news alerts
- Stem Cell Therapies Market Volume Forecast and Value Chain Analysis 2015 - 2025
- Small Animal Imaging (In Vivo) Market to Witness Robust Expansion throughout the Forecast 2016- 2026
- Advance Renal Cell Carcinoma Therapeutics Market Prophesied to Grow at a Faster Pace by 2026
- Nasal Implant Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026
- Equine Veterinary Therapeutics Market Growth, Trends, Absolute Opportunity and Value Chain 2016-2026
- Limb Salvage Systems Market Value Share, Supply Demand, share and Value Chain 2016-2026
PMHub
Digitas Health
Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....
Latest intelligence
- Innovation in merger control and the impact on the pharmaceutical sector
- Is focusing on pipeline products enough to assess regulatory risks?...
- Nudge-nudge, think-think
- Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
- Quality in Care Diabetes 2018: the best in innovative diabetes care
- Awards highlight new evidence-based approaches to improving care...
Quick links
Infographics
